Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Retained Earnings (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Retained Earnings readings, the most recent being -$249.0 million for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 31.06% to -$249.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$249.0 million, a 31.06% decrease, with the full-year FY2025 number at -$249.0 million, down 31.06% from a year prior.
  • Retained Earnings hit -$249.0 million in Q4 2025 for Treace Medical Concepts, down from -$239.6 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $191000.0 in Q3 2024 to a low of -$249.0 million in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$82.5 million (2022), compared with a mean of -$97.0 million.
  • Biggest five-year swings in Retained Earnings: skyrocketed 100.15% in 2024 and later tumbled 858784.62% in 2025.
  • Treace Medical Concepts' Retained Earnings stood at -$41.9 million in 2021, then plummeted by 102.17% to -$84.7 million in 2022, then plummeted by 58.46% to -$134.2 million in 2023, then plummeted by 41.52% to -$190.0 million in 2024, then plummeted by 31.06% to -$249.0 million in 2025.
  • The last three reported values for Retained Earnings were -$249.0 million (Q4 2025), -$239.6 million (Q3 2025), and -$223.3 million (Q2 2025) per Business Quant data.